What does Dr. PAUL GEUKENS Sprl do?

Dr. PAUL GEUKENS Sprl is a specialist medical practice in Rixensart. Private Limited, started on 27 September 2017, 1 establishment.

What is the address of Dr. PAUL GEUKENS Sprl?

The registered office of Dr. PAUL GEUKENS Sprl is located at Rue de La Hulpe 98 box A, 1331 Rixensart.

Is Dr. PAUL GEUKENS Sprl still active?

Yes. According to the CBE (30 September 2026) Dr. PAUL GEUKENS Sprl is active, legal situation “Normale toestand”, started on 27 September 2017.

Is Dr. PAUL GEUKENS Sprl registered on Peppol?

Yes, Dr. PAUL GEUKENS Sprl is registered on the Peppol network with ID 0208:0681819235.

What is the enterprise number of Dr. PAUL GEUKENS Sprl?

The enterprise number of Dr. PAUL GEUKENS Sprl is BE0681819235.

When was Dr. PAUL GEUKENS Sprl founded?

Dr. PAUL GEUKENS Sprl was founded on 27 September 2017.

Who are the directors of Dr. PAUL GEUKENS Sprl?

According to the 2025 annual accounts, the directors of Dr. PAUL GEUKENS Sprl are: PAUL GEUKENS.

Is Dr. PAUL GEUKENS Sprl a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 September 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. PAUL GEUKENS Sprl make in 2025?

Dr. PAUL GEUKENS Sprl posted a profit after taxes of € 105,556 in financial year 2025.

What is the revenue of Dr. PAUL GEUKENS Sprl?

As a small company, Dr. PAUL GEUKENS Sprl is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 188,648.

Dr. PAUL GEUKENS Sprl (Private Limited) - Rixensart

Dossier Dr. PAUL GEUKENS Sprl, printed on 30 September 2026 from databakkes.be/en/0681819235/dr-paul-geukens-sprl. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. PAUL GEUKENS Sprl from Rixensart, company number BE0681819235, closed financial year 2025 with a result of € 105,556 after tax. For that financial year Dr. PAUL GEUKENS Sprl recorded a gross margin of € 188,648 and equity of € 20,460. Compared with financial year 2024, the result moved from € 88,930 to € 105,556. Profitable, and profit is growing. The buffer shrank hard: equity is 77 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.

What it is worth Shrank hard

€ 20,460

▼ 77% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 105,556

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 46,067

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 175,857 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 49,611

▲ € 48,633 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 24,342

€ 9,881 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes and wages

€ 6,678

▲ 67% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 179,150 Gross margin 2022: € 179,150 First fiscal year in the series	€ 147,957 Gross margin 2023: € 147,957 ▼ 17% vs 2022 (€ 179,150) Unfavourable step	€ 158,334 Gross margin 2024: € 158,334 ▲ 7% vs 2023 (€ 147,957) Favourable step	€ 188,648 Gross margin 2025: € 188,648 ▲ 19% vs 2024 (€ 158,334) Favourable step	▲ 19%
Profit after taxes	€ 96,779 Profit after taxes 2022: € 96,779 First fiscal year in the series	€ 81,041 Profit after taxes 2023: € 81,041 ▼ 16% vs 2022 (€ 96,779) Unfavourable step	€ 88,930 Profit after taxes 2024: € 88,930 ▲ 10% vs 2023 (€ 81,041) Favourable step	€ 105,556 Profit after taxes 2025: € 105,556 ▲ 19% vs 2024 (€ 88,930) Favourable step	▲ 19%
Equity	€ 241,044 Equity 2022: € 241,044 First fiscal year in the series	€ 241,044 Equity 2023: € 241,044 Unchanged (€ 241,044) Unchanged	€ 90,761 Equity 2024: € 90,761 ▼ 62% vs 2023 (€ 241,044) Unfavourable step	€ 20,460 Equity 2025: € 20,460 ▼ 77% vs 2024 (€ 90,761) Unfavourable step	▼ 77%
Total debts	€ 198,209 Total debts 2022: € 198,209 First fiscal year in the series	€ 115,555 Total debts 2023: € 115,555 ▼ 42% vs 2022 (€ 198,209) Favourable step	€ 129,474 Total debts 2024: € 129,474 ▲ 12% vs 2023 (€ 115,555) Unfavourable step	€ 184,286 Total debts 2025: € 184,286 ▲ 42% vs 2024 (€ 129,474) Unfavourable step	▲ 42%
Cash	€ 212,214 Cash 2022: € 212,214 First fiscal year in the series	€ 162,080 Cash 2023: € 162,080 ▼ 24% vs 2022 (€ 212,214) Unfavourable step	€ 67,909 Cash 2024: € 67,909 ▼ 58% vs 2023 (€ 162,080) Unfavourable step	€ 46,067 Cash 2025: € 46,067 ▼ 32% vs 2024 (€ 67,909) Unfavourable step	▼ 32%
Retained profit	€ 222,444 Retained profit 2022: € 222,444 First fiscal year in the series	€ 222,444 Retained profit 2023: € 222,444 Unchanged (€ 222,444) Unchanged	€ 72,161 Retained profit 2024: € 72,161 ▼ 68% vs 2023 (€ 222,444) Unfavourable step	€ 1,860 Retained profit 2025: € 1,860 ▼ 97% vs 2024 (€ 72,161) Unfavourable step	▼ 97%
Dividend	€ 96,779 Dividend 2022: € 96,779 First fiscal year in the series	€ 81,041 Dividend 2023: € 81,041 ▼ 16% vs 2022 (€ 96,779) Unchanged	€ 239,212 Dividend 2024: € 239,212 ▲ 195% vs 2023 (€ 81,041) Unchanged	€ 175,857 Dividend 2025: € 175,857 ▼ 26% vs 2024 (€ 239,212) Unchanged	▼ 26%
Bank debt	€ 18,299 Bank debt 2022: € 18,299 First fiscal year in the series	€ 3,676 Bank debt 2023: € 3,676 ▼ 80% vs 2022 (€ 18,299) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 3,676) Favourable step	€ 24,342 Bank debt 2025: € 24,342 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 439,253 Balance sheet total 2022: € 439,253 First fiscal year in the series	€ 356,599 Balance sheet total 2023: € 356,599 ▼ 19% vs 2022 (€ 439,253) Unchanged	€ 220,236 Balance sheet total 2024: € 220,236 ▼ 38% vs 2023 (€ 356,599) Unchanged	€ 204,746 Balance sheet total 2025: € 204,746 ▼ 7% vs 2024 (€ 220,236) Unchanged	▼ 7%

Key figures of Dr. PAUL GEUKENS Sprl, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. PAUL GEUKENS Sprl?

What happened at Dr. PAUL GEUKENS Sprl in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 30, 2026 New annual accounts for financial year 2025: profit of € 105,556 (▲ 19% vs 2024). Source: NBB ↗
Sep 27, 2017 New establishment in Rixensart. KBO
Sep 27, 2017 Start of the company according to the CBE. KBO

In short

From € 96,779 profit in 2022 to € 105,556 profit in 2025.

Paid € 103,043 in corporate taxes since 2022.

Best year ever: 2025, with € 105,556 profit.

Paid out € 592,890 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. PAUL GEUKENS Sprl? We notify you, reason included.

Follow Dr. PAUL GEUKENS Sprl

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

PAUL GEUKENS

Dr. PAUL GEUKENS Sprl

Behind Dr. PAUL GEUKENS Sprl is PAUL GEUKENS.

See the full network in the app

Directors

According to the 2025 annual accounts

PAUL GEUKENS

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de La Hulpe 98 box A

1331 Rixensart

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Ultrasound and Emergency Medecine

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0681.819.235
VAT number: BE 0681.819.235
Registered office: Rue de La Hulpe 98 bus A, 1331 Rixensart
Names & denominations: Dr. PAUL GEUKENS Sprl
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 September 2017
Peppol: Active · Active since 19 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗